Project Grant 2213155
Award Date
3/1/23
Completion Date
2/29/24
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Cordova, TN 38016, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $275,000 awarded to Xtract Medical Inc. aims to develop and demonstrate the feasibility of a novel catheter-based system for improved removal of blood clots during mechanical thrombectomy procedures to treat venous thromboembolism (VTE). The proposed system is designed to effectively remove large blood clots while minimizing damage to blood vessels and reducing complications such as...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
Venarum Medical LLC received a $255,619 Project Grant award from the National Science Foundation on August 15, 2021 to support research and development activities concluding on May 31, 2022. The funding was provided through the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence. Specifically, the grant supports Venarum Medical's "SBIR PHASE I: INTEGRATED MANUFACTURING OF ARTIFICIAL VALVES FOR...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I project under CFDA 47.084 - NSF Technology, Innovation, and Partnerships provides $275,000 to Medfree Inc., a minority-owned small business, to develop a novel, transcatheter device and procedure for the minimally invasive surgical revision and repair of the tricuspid valve. The project aims to address the significant unmet need for percutaneous treatment options for the over 1.6 million U.S. patients...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,976 to Ecate LLC aims to develop a novel intraspinal stimulator system to restore sensation and volitional motor control in spinal cord injury patients. The project will fabricate nanopatterned stimulating electrodes coupled with custom CMOS chips to deliver spatially selective electrical stimulation to the spinal cord. This closed-loop neural interface system is intended...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $304,906 to Seabird Lifesciences LLC provides funding to develop an innovative bioprinting approach for creating vascular grafts that closely mimic the properties of natural blood vessels. The research objectives include optimizing a custom bioprinting system for a Dacron-recombinant human collagen blend, fine-tuning material compositions to achieve desired mechanical...
This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to President and Fellows of Harvard College (Harvard University) provides $550,000 in funding from August 1, 2024 to July 31, 2026 to develop a minimally-invasive, catheter-based additive manufacturing platform capable of creating customized medical implants directly inside the human body. The project aims to transform the field of medical implants by enabling on-demand fabrication of personalized 3D-printed...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded Corvion, Inc. a $1,024,635 SBIR Direct to Phase II Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a Totally Implanted Left Ventricular Assist Device (TI-LVAD). This medical device aims to provide an improved treatment option for the ~6.5 million Americans suffering from heart failure by reducing complications and enhancing patient quality of...
This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, provides $920,176 under the Cardiovascular Diseases Research program to develop a smart aspiration catheter with fiber optic pressure sensors for mechanical thrombectomy procedures to treat acute ischemic stroke. The catheter will be designed, prototyped and validated at Worcester Polytechnic Institute to provide real-time data to interventionalists on the interaction...
This $596,582 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of Neuronoff Inc.'s Injectrode technology. The Injectrode is an injectable, flexible electrode designed for less invasive neural modulation therapies. The grant will fund the optimization and validation of the Injectrode for baroreceptor activation therapy to treat hypertension and heart failure. Neuronoff Inc. also...